Curious about how the #Covid19 vaccine trials are going? #TheHighWire looks inside the Lancet’s latest study on #AstraZeneca’s vaccine being tested at #OxfordUniversity…and the numbers are shockinghttps://t.co/2ZRS9aiWme
— The HighWire (@HighWireTalk) August 3, 2020
“AstraZeneca has been granted protection from future product liability claims related to its COVID-19 vaccine hopeful by most of the countries with which it has struck supply agreements” https://t.co/racPE4I7Tk
— The HighWire (@HighWireTalk) August 1, 2020
About 5,000 Brazilian health care workers are expected to receive a trial coronavirus vaccine from Oxford University and multinational drugmaker AstraZeneca, along with volunteers in the UK and South Africa. @npwcnn reports.https://t.co/nXgT7anDL0 pic.twitter.com/yE4YeJ0dDv
— New Day (@NewDay) July 27, 2020
"The Johnson & Johnson vaccine is a particulary good, low-cost vaccine. The AstraZeneca and Moderna are two of the first to get out there," says @BillGates on what companies are winning the race for the #COVID19 vaccine. pic.twitter.com/MFqGCF1Z4d
— Squawk Box (@SquawkCNBC) July 28, 2020
If Oxford University's vaccine proves effective against covid-19, AstraZeneca, a British pharmaceutical company, have said that making each dose would cost about as much as a cup of coffee. From July https://t.co/k48XUWpkpd
— The Economist (@TheEconomist) August 3, 2020
Vaccine trials were promising.
Oxford University’s vaccine, developed in collaboration with Astrazeneca, is now more likely to succeed than to fail.
And behind it comes a stream of other vaccines, some of which will surely work: https://t.co/U0CVgnN5LY
— Matt Ridley (@mattwridley) July 27, 2020
A senior executive of AstraZeneca has revealed in shocking details that the company could not be on receiving end of any constitutional motion or face legal action for any possible side effects or unwanted reactions induced by its Covid-19 vaccine.https://t.co/Q53SPaHuJ5
— GreatGameIndia (@GreatGameIndia) August 4, 2020
Emergent signs $174 million deal to make AstraZeneca's potential COVID-19 vaccine https://t.co/MARtiCGAHY pic.twitter.com/MbhfnQYQfG
— Reuters (@Reuters) July 27, 2020
Promising news from Swedish–British AstraZeneca on a Covid-19 vaccine in the making.#staysafe https://t.co/YejxNYZZRJ
— Sweden.se (@swedense) July 29, 2020
AstraZeneca: won't profit from COVID-19 vaccine in pandemic https://t.co/kwpgMo0HRV pic.twitter.com/Z3UnSqR53c
— CTV News (@CTVNews) July 30, 2020
Shares of Moderna have soared 299% since the start of the year, and BioNTech’s are up 152%. Investors are clearly enthusiastic about vaccines but @jimwillhite explains why those valuations might not last. #WSJWhatsNow pic.twitter.com/P7H90MBy4F
— The Wall Street Journal (@WSJ) August 4, 2020
https://twitter.com/HegKong/status/1289497197696884736
Moderna CMO sells shares as final vaccine trials begin, raising concerns
CEO Stéphane Bancel has also cashed out on shares in recent months.https://t.co/bBybp5WYuy
— sally (@sallyKP) August 3, 2020
PANIC at the GATES? Moderna CMO Ditches All His Shares & CEO sell shares as final vaccine trials begin, raising concerns https://t.co/8pGttfT5CT
— Thomas Paine (@Thomas1774Paine) August 4, 2020
We are proud to celebrate RNA Day! #RNA #mRNA pic.twitter.com/2wKfFw09B5
— Moderna (@moderna_tx) August 1, 2020
Bill Gates caught on video admitting that his ‘experimental’ vaccine will CHANGE our DNA FOREVER.
He’s experimenting with human beings like we are a tesr crop of GMO corn or barley!
— BeachMilk (@BeachMilk) July 27, 2020
The U.S. vaccine effort has moved fast. But scientists fear White House pressure to deliver by the election may compromise safety and effectiveness. https://t.co/QeT5Vj41ey
— The New York Times (@nytimes) August 3, 2020
There is now evidence that HHS taking away CDC control of #COVID19 hospitalization data went badly. But that’s just one of many deep problems with public health data collection in the US. Me in @WIRED: https://t.co/GiFgig5Ezj
— Maryn McKenna (@marynmck) July 30, 2020
USA: Senators plan to introduce the Coronavirus consumer data protection bill | https://t.co/AenORhVp30 | #DataCollection #DataProcessing #Geolocation #Health #Pharmaceutical #OptIn #OptOut pic.twitter.com/lRxNBGKlzS
— OneTrust DataGuidance (@DataGuidance) May 7, 2020
“Some pharmaceutical companies are failing to share data…” Big Pharma 🙁
The race to find a coronavirus treatment has one major obstacle: big pharma https://t.co/9gGV0Cloe3
— Help others. Humanity will endure. (@marvicleonen) April 3, 2020
With the pharmaceutical innovation and the current #covid19 situation @EMA_News provided a comprehensive guidance on the application of #data protection rules for the development of #medicines and public health purposes
Find out more here:https://t.co/C7xVUDbZQq pic.twitter.com/WoH9hcic5R— ECCRT (@ECCRT) May 28, 2020
Before we give control over our personal data to fucking Mike Bloomberg @NYGovCuomo, lets see if these pharmaceutical can act as an inhibitor against #COVID19. https://t.co/Fmv0j43TdV
— JQ LLC / Impunity City (@jqllc) April 23, 2020
A loose alliance of #pharma companies including Gilead, Novartis, Schrödinger, Takeda Pharmaceutical, and WuXi AppTec has formed to share ideas, resources, and data to develop custom pan-coronavirus #antivirals. https://t.co/D0H4iW3ioc #COVID19
— C&EN (@cenmag) May 4, 2020
Coronavirus Drug: #Biocon to submit more data on #Itolizumab to Covid taskforce https://t.co/Bpy7eIPM52 via @FinancialXpress
— Biocon (@Bioconlimited) July 28, 2020
What is the status of potential treatments for #COVID19? Navitus is tracking the latest data and impact on the pharmaceutical supply chain. https://t.co/Zq0ogwVHyS
— Navitus (@navituspbm) April 9, 2020
Our data is a strong early indicator of how hospitals are prioritizing drugs, devices and supplies in their efforts to treat and mitigate #COVID19. Learn more about how we’re tracking pharmaceutical demand during #coronavirus.https://t.co/SJIkD1ySSU pic.twitter.com/tUJpCP27Eg
— Premier Inc. (@PremierHA) March 31, 2020
#coronavirus News Alert: Dr. Vladimir Zelenko, a board-certified family practitioner in NY, has now treated 699 Covid-19 patients with 100% success using Hydroxychloroquine Sulfate, Zinc and Z-Pak. All symptoms of shortness of breath resolved within 4-6 hr https://t.co/siCvNg845Q pic.twitter.com/lOrUvBHp0A
— Adam Milstein (@AdamMilstein) March 29, 2020
Regulators in #India approved a #Pharmaceutical to fight mild/medium #COVID19 cases. However, some in the #Indian medical community ask for more #Data around the #clinicaltrials. Please watch this #Video by Clinical Trials TV to learn more and follow us on Twitter.#coronavirus pic.twitter.com/dmMyRdIHSo
— Clinical Trials TV (@ClinTrialsTV) June 25, 2020
#abbottlabs false negatives – #FDA @US_FDA data suggests Abbott's rapid coronavirus diagnostic test is delivering inaccurate results, pummeling the pharmaceutical company stocks following U.S. Food and Drug Administration warning from @CNBC https://t.co/iWF2pLJKYn
— Ayoka Systems (@ayokasystems) May 15, 2020
Novel Coronavirus Research at the Advanced Photon Source https://t.co/iOK1SFuT2S DOE Office of Science facilities study SARS-CoV-2 virus incl. DOE's Advanced Photon Source at Argonne National Laboratory, groups who operate x-ray facilities there, researchers who use facilities pic.twitter.com/JMd3rW7ohO
— AdvancedPhotonSource (@advancedphoton) June 29, 2020
pharmaceutical giants have branded as “nonsense” a voluntary scheme to share information, including trial data and patent rights, to develop and widely distribute #COVID19 treatments, vaccines, and diagnostics by WHO https://t.co/1d3PclWr78
— COVID19 in Asia-Pacific (@SEACoronavirus) May 30, 2020
“Ultimately, we might be able to use this data for things like susceptibility to drugs or a vaccine,” said Dr. Robert Siegel, a Stanford infectious disease expert. “We’re not there yet.” https://t.co/p9dGTeyvvV
— San Francisco Chronicle (@sfchronicle) July 30, 2020
Inovio Senior VP of Research and Development Dr. Kate Broderick says coronavirus vaccine trial data from her company is ‘incredibly promising.’https://t.co/7336eSQ4CH
— Neil Cavuto (@TeamCavuto) July 30, 2020
Highlight: @moderna_tx is entering phase 3 of its coronavirus vaccine trial. "We'll be able to see… what is the safety and the efficacy of a vaccine," CEO @sbancel says. "Given the higher infection rate in southern states… it's possible we have data in October or November." pic.twitter.com/miiptxQ8mC
— Yahoo Finance (@YahooFinance) July 27, 2020
Bill Gates says all the coronavirus vaccine candidates for which there is data would require multiple doses.
"If we look at the effectiveness on the elderly, some of the constructs might require more than two doses to get the kind of protection we want." #CNNTownHall pic.twitter.com/zDm4OwGCgU
— Anderson Cooper 360° (@AC360) July 24, 2020
10/10 Vaccine … encouraging data from preliminary studies, but most vaccines don’t make it to approval, most being developed use unproven technologies, and we don’t know if they will work and be safe. Most importantly, we must be frank and restore trust.https://t.co/NrVssBn2uX
— Dr. Tom Frieden (@DrTomFrieden) July 31, 2020
$VXRT 3 Small Biotechs in Focus on Promising Coronavirus Vaccine Data => https://t.co/BgPs2003YD
#Vaxart #Pharmaceuticals #COVID2019 #COVID19 #Coronavirus #Vaccine #Biotechnology #BioTech #Stock #VXRT— MichaelSDeVries (@MichaelSDeVries) July 22, 2020
What the data shows so far. #CoronavirusVaccine https://t.co/pikkS59PtG
— Cleveland Clinic Children’s (@CleClinicKids) July 30, 2020
J&J's COVID-19 Vaccine Generates Antibodies in Primates, Preclinical Data Shows#biospace #lifesciences #biotechnology #pharmaceuticals#COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccinehttps://t.co/lHP64DapXG
— BioSpace (@biospace) July 30, 2020
Moderna and NIAID Publish Positive COVID-19 Vaccine Data in Monkeys#biospace #lifesciences #biotechnology #pharmaceuticals#COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccinehttps://t.co/piemfcjqTm
— BioSpace (@biospace) July 29, 2020
#Covid19: $PFE, $BNTX rise on U.K. supply deal for #coronavirus vaccine. Meanwhile, $AZN and Oxford data fail to impress. #stocks #biotech #pharmaceuticals #investingnews https://t.co/qI2wfCR1TR
— Allison Gatlin (@IBD_AGatlin) July 20, 2020
Oxford University and pharmaceutical giant AstraZeneca's potential coronavirus vaccine has produced a promising immune response in a large, early-stage human trial, according to newly released data. https://t.co/ErIG7YEkhm
— CNBC (@CNBC) July 20, 2020
And we are making progress! Vaccine results are promising! And rapid testing is coming! Both will be a big help, and the vaccine could help us get to a herd-immunity-like state.https://t.co/PdATSmD518https://t.co/12oEOfwjFj
— Geoff Brumfiel (@gbrumfiel) July 24, 2020
In the race to develop a new #COVID19 vaccine, two pharmaceutical companies Moderna and AstraZeneca have released promising data on their vaccines.https://t.co/V8lNWbQ6r4
— MedShadow Foundation (@Med_Shadow) July 23, 2020
Like most, I am keen to see a vaccine for #COVID19. It reinforces the importance of #science #stem #research #data (shout out to my daughter in her pharmaceutical science honours year at @MonashUni).
This tracker shows how close we are… https://t.co/Bjo7UDT9Ol— Jo Mikleus (@JoMikleus) July 18, 2020
'Coronavirus vaccine progressing well, got good data,' says AstraZeneca https://t.co/lBbA0SlK4O
— Business Today (@BT_India) July 31, 2020
And how exactly will they let the data from Caputo's political hands to figure out priorities?
That committee of experts is developing a framework to help the federal advisory panel and the CDC set final vaccination priorities.https://t.co/OsI12E5Viz
— 🍿Justice is Served (@pleasesaveour) July 30, 2020
Antibodies have become a familiar word in the pandemic era, perhaps suggesting they’re the best hope for keeping the deadly coronavirus at bay. But when crucial vaccine data was released this week, the spotlight panned to an unsung immune player: T cells. https://t.co/UdO7jG62P9
— New York Daily News (@NYDailyNews) July 26, 2020
Gilead Stock Is Dropping https://t.co/Ja30JW7iTI via @BarronsOnline
— MacKenzie (@Smackenziekerr) July 31, 2020
"there is a tradition among vaccinologists of injecting themselves as a quick and cheap way to get data" https://t.co/Q48DjefiUZ
— Jesse Walker (@notjessewalker) August 1, 2020
Vaccine for Coronavirus COVID
All good so far – effective, safe?
What data is being hidden?
Is medical science working for the pharmaceutical industry – yet again?https://t.co/DrRpxI0C1x— Steve Scrutton (@stevescrutton) July 24, 2020
#COVID19 has brought the pharmaceutical industry together in an unprecedented global response. Read about collaborations with @CEPIvaccines and how companies are sharing data and resources to accelerate the search for a vaccine https://t.co/8XQRjP3m3w
— Innovative Medicines (@innovativemeds) April 12, 2020
A coronavirus vaccine is in the works and is showing promising results in animal subjects. The next essential piece of the puzzle: human data. https://t.co/jYnuOGP987
— NYT Business (@nytimesbusiness) July 29, 2020
This is an essential step because it is necessary to have data within the country before the #vaccine is administered to Indians, Department of Biotechnology (#DBT) Secretary Renu Swarup said.#Coronavirushttps://t.co/RbKfZBXlJy
— IndiaToday (@IndiaToday) July 27, 2020
The FDA could issue an emergency use authorization for a coronavirus vaccine in a “matter of weeks” after clinical trial data meet the requirements for efficacy, according to a top FDA official. https://t.co/qchL2ucLkr pic.twitter.com/tbnGKkvi31
— WebMD (@WebMD) July 30, 2020
U.S. must spend $75 billion to fix flawed Covid-19 testing, report says. "America faces an impending disaster."https://t.co/uUH3k0BUdd
— Matthew Herper (@matthewherper) July 16, 2020
#NSTworld A #Covid19 coronavirus vaccine has for the first time "largely protected" monkeys from infection during an animal trial, data from a #Chinese pharmaceutical giant showed.https://t.co/wnovntm9Pe
— New Straits Times (@NST_Online) April 25, 2020
A novel #coronavirus vaccine has for the first time “largely protected” monkeys from infection during an animal trial, data from a Chinese pharmaceutical giant showed.https://t.co/gddZKp07ky pic.twitter.com/XcTcpVGQNq
— Dawn.com (@dawn_com) April 25, 2020
U.S. adversaries have been hacking coronavirus-related vaccine data from American universities, pharmaceutical companies, and healthcare firms in a global competition to develop the first viable COVID-19 vaccine.https://t.co/9LIjvb54Y9
— The Soufan Center (@TheSoufanCenter) July 24, 2020
#coronavirus: Rival states targeted #UK and #US coronavirus labs with 'malicious cyber campaigns'
State-backed cyber attackers are trying to steal data from universities, pharmaceuticals & research institutes involved in the coronavirus response.https://t.co/LbBz1Z6Jdp
— Indo-Pacific News (@IndoPac_Info) May 6, 2020
It's the latest attempt by hackers to steal #COVID19 research data. https://t.co/siQMFoArHi
— Digital Trends (@DigitalTrends) July 23, 2020
Hackers linked to China's government targeted biotech company Moderna INC, a leading U.S.-based coronavirus vaccine research developer, earlier this year in a bid to steal valuable data, according to a U.S. security official tracking Chinese hacking activity. pic.twitter.com/ELsO9QMEDQ
— ANews (@anewscomtr) July 31, 2020
"China’s state-run hacking groups suspected of attacking U.S. research institutions and pharmaceutical companies to steal #COVID19 data, treatments and vaccines." #CCP #CyberSecurity #ChinaLiedPeopleDied #COVIDー19 #CyberCrime #3moremonthshttps://t.co/pXTnxEekfC
— NoBeard The Pirate ³³º¹ (@NoBeardEcho6) May 13, 2020
"…(US) issued a "public service announcement" warning that China is likely launching cyberattacks to steal coronavirus data related to vaccines and treatments from US research institutions and pharmaceutical companies, calling it a "significant threat.""https://t.co/E1A8N5FHoa
— Amit Paranjape (@aparanjape) May 13, 2020
Russian hackers are trying to steal COVID-19 vaccine and treatment research from pharmaceutical and academic institutions, according to Britain's National Cyber Security Centre https://t.co/s8Uwogs4rS
— Reuters (@Reuters) July 16, 2020
Russia intends to be the first in the world to approve a coronavirus vaccine, in less than two weeks — despite concerns about its safety, effectiveness and over whether the country has cut essential corners in development, CNN has learnedhttps://t.co/aDJENEXFS9
— KTLA (@KTLA) July 29, 2020